✦ LIBER ✦

The Reason for Discontinuation of the First Tumor Necrosis Factor (TNF) Blocking Agent Does Not Influence the Effect of a Second TNF Blocking Agent in Patients with Rheumatoid Arthritis

✍ Scribed by BLOM, M.; KIEVIT, W.; FRANSEN, J.; KUPER, I. H.; den BROEDER, A. A.; De GENDT, C. M.A.; JANSEN, T. L.; BRUS, H. L.M.; van de LAAR, M. A.F.J.; van RIEL, P. L.C.M.

Book ID: 126664705
Publisher: Journal of Rheumatology Publishing Company
Year: 2009
Tongue: English
Weight: 218 KB
Volume: 36
Category: Article
ISSN: 0315-162X
DOI: 10.3899/jrheum.090054

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The comparative effectiveness of tumor n

The comparative effectiveness of tumor necrosis factor–blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis: A six-month, longitudinal, observational, multicenter study

✍ Marte S. Heiberg; Bjørn-Yngvar Nordvåg; Knut Mikkelsen; Erik Rødevand; Cecilie K 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

Modeling the 5-year cost effectiveness o

Modeling the 5-year cost effectiveness of treatment strategies including tumor necrosis factor-blocking agents and leflunomide for treating rheumatoid arthritis in the Netherlands

✍ Welsing, Paco M. J. ;Severens, Johan L. ;Hartman, Margriet ;van Riel, Piet L. C. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

Regression of subacute cutaneous lupus e

Regression of subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis treated with a biologic tumor necrosis factor α–blocking agent: Comment on the article by Pisetsky and the letter from Aringer et al

✍ Bruno Fautrel; Violaine Foltz; Camille Frances; Pierre Bourgeois; Sylvie Rozenbe 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 700 KB